Dr Briony Kate Larance
Adjunct Senior Lecturer

Dr Briony Kate Larance

medicine-health
National Drug&Alcohol Research

PhD, BSc (Psych) (Hons) - Briony Larance is a Conjoint Senior Research Fellow at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, and a Senior Research Fellow and Vice Chancellor’s postdoctoral fellow at the University of Wollongong.  She completed a National Health and Medical Research Council (NHMRC) early-career research fellowship (2014-2018) at NDARC examining the trajectories and health consequences of pharmaceutical opioid use. Her research interests include the use and extra-medical use of pharmaceutical opioids, 'abuse-deterrent' formulations, treatment of substance use disorders, opioid dependence, the use of anabolic steroids, and interventions to improve the health and wellbeing of people who inject drugs. She has been involved in epidemiological and clinical studies utilising a range of methods including randomised-controlled trials, post-marketing surveillance studies, illicit drug surveillance, analyses of linked administrative data and cohort studies. Her current projects include: developing and validating an opioid-related behaviour scale; a prospective cohort study of people prescribed opioids for non-cancer pain; a post-marketing study of tapentadol; a mixed-methods study to increase the capacity of a regional Local Health District to respond to methamphetamine-related harm; and an implementation trial of long-acting (depot) buprenorphine injections for opioid dependence.

Phone
02 9385 0333

Publications

  • Book Chapters | 2020
    Dr Briony Kate Larance
    Farrell M; Larance B; Breen C, 2020, 'Opioids', in New Oxford Textbook of Psychiatry, Oxford University Press, pp. 507 - 518, http://dx.doi.org/10.1093/med/9780198713005.003.0051
    Books | 2007
    Dr Briony Kate Larance
    Gibson AE; Larance BK; Roxburgh AD; Degenhardt LJ; Black E, 2007, The extent of diversion of fentanyl for non-medical puposes in Australia: What do we know?, Original, National Drug & Alcohol Research Centre, Randwick, NSW
  • Journal articles | 2021
    Dr Briony Kate Larance
    Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, vol. 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715
    Journal articles | 2021
    Dr Briony Kate Larance
    Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, vol. 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297
    Journal articles | 2021
    Dr Briony Kate Larance
    Kelly PJ; Deane FP; Davis EL; Hudson S; Robinson LD; Keane CA; Hatton EL; Larance B, 2021, 'Routine outcome measurement in specialist non-government alcohol and other drug treatment services: Establishing effectiveness indicators for the NADAbase', Drug and Alcohol Review, vol. 40, pp. 540 - 552, http://dx.doi.org/10.1111/dar.13191
    Journal articles | 2021
    Dr Briony Kate Larance
    Osborne B; Kelly PJ; Robinson LD; Ivers R; Deane FP; Larance B, 2021, 'Facilitators and barriers to integrating physical health care during treatment for substance use: A socio-ecological analysis', Drug and Alcohol Review, vol. 40, pp. 607 - 616, http://dx.doi.org/10.1111/dar.13197
    Journal articles | 2021
    Dr Briony Kate Larance
    Kelly PJ; Hatton EL; Hinsley K; Davis E; Larance B, 2021, 'Preliminary psychometric evaluation of the patient reported experience measure for addiction treatment (PREMAT)', Addictive Behaviors, vol. 123, pp. 107048 - 107048, http://dx.doi.org/10.1016/j.addbeh.2021.107048
    Journal articles | 2021
    Dr Briony Kate Larance
    Kelly PJ; McCreanor K; Beck AK; Ingram I; O'Brien D; King A; McGlaughlin R; Argent A; Ruth M; Hansen BS; Andersen D; Manning V; Shakeshaft A; Hides L; Larance B, 2021, 'SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups', Journal of Substance Abuse Treatment, pp. 108568 - 108568, http://dx.doi.org/10.1016/j.jsat.2021.108568
    Journal articles | 2021
    Dr Briony Kate Larance
    Beck AK; Larance B; Deane FP; Baker AL; Manning V; Hides L; Shakeshaft A; Argent A; Kelly PJ, 2021, 'The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data', Drug and Alcohol Dependence, vol. 225, http://dx.doi.org/10.1016/j.drugalcdep.2021.108814
    Journal articles | 2021
    Dr Briony Kate Larance
    Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, vol. 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360
    Journal articles | 2021
    Dr Briony Kate Larance
    Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, vol. 4, pp. e213059, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059
    Journal articles | 2021
    Dr Briony Kate Larance
    Robinson LD; Kelly PJ; Larance BK; Griffiths S; Deane FP, 2021, 'Eating Disorder Behaviours and Substance Use in Women Attending Treatment for Substance Use Disorders: a Latent Class Analysis', International Journal of Mental Health and Addiction, http://dx.doi.org/10.1007/s11469-021-00497-z
    Journal articles | 2020
    Dr Briony Kate Larance
    Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care Settings', Pain medicine (Malden, Mass.), vol. 21, pp. e79 - e88, http://dx.doi.org/10.1093/pm/pnz213
    Journal articles | 2020
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, vol. 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941
    Journal articles | 2020
    Dr Briony Kate Larance
    Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, vol. 9, pp. e15113, http://dx.doi.org/10.2196/15113
    Journal articles | 2020
    Dr Briony Kate Larance
    Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, vol. 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389
    Journal articles | 2020
    Dr Briony Kate Larance
    Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', EClinicalMedicine, vol. 28, pp. 100592 - 100592, http://dx.doi.org/10.1016/j.eclinm.2020.100592
    Journal articles | 2020
    Dr Briony Kate Larance
    Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, vol. 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021
    Journal articles | 2020
    Dr Briony Kate Larance
    Osborne B; Kelly PJ; Larance B; Robinson LD; Ivers R; Deane FP; Webber A; Kelly D, 2020, 'Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service', Journal of Dual Diagnosis, vol. 16, pp. 250 - 259, http://dx.doi.org/10.1080/15504263.2019.1704960
    Journal articles | 2020
    Dr Briony Kate Larance
    Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, vol. 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
    Journal articles | 2019
    Dr Briony Kate Larance
    Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, vol. 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729
    Journal articles | 2019
    Dr Briony Kate Larance
    Larance B; Campbell G; Moore T; Nielsen S; Bruno R; Lintzeris N; Cohen M; Hall W; Mattick R; O'Donnell C; Degenhardt L, 2019, 'Concerns and help-seeking among patients using opioids for management of chronic noncancer pain', Pain Medicine (United States), vol. 20, pp. 758 - 769, http://dx.doi.org/10.1093/pm/pny078
    Journal articles | 2019
    Dr Briony Kate Larance
    Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), vol. 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009
    Journal articles | 2019
    Dr Briony Kate Larance
    Campbell G; Lintzeris N; Gisev N; Larance B; Pearson S; Degenhardt L, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, vol. 210, pp. 6 - 8, http://dx.doi.org/10.5694/mja2.12047
    Journal articles | 2019
    Dr Briony Kate Larance
    Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting', Addiction, vol. 114, pp. 389 - 399, http://dx.doi.org/10.1111/add.14380
    Journal articles | 2019
    Dr Briony Kate Larance
    Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, vol. 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683
    Journal articles | 2019
    Dr Briony Kate Larance
    Shanahan M; Larance B; Nielsen S; Cohen M; Schaffer M; Campbell G, 2019, 'A protocol for a discrete choice experiment: Understanding patient medicine preferences for managing chronic non-cancer pain', BMJ Open, vol. 9, http://dx.doi.org/10.1136/bmjopen-2018-027153
    Journal articles | 2019
    Dr Briony Kate Larance
    Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2019, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, http://dx.doi.org/10.1080/08897077.2019.1635954
    Journal articles | 2019
    Dr Briony Kate Larance
    Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L, 2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, vol. 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0
    Journal articles | 2019
    Dr Briony Kate Larance
    Campbell G; Larance B; Lintzeris N, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, vol. 211, pp. 237 - 237.e1, http://dx.doi.org/10.5694/mja2.50303
    Journal articles | 2019
    Dr Briony Kate Larance
    Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B, 2019, 'Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015', Drug and Alcohol Review, vol. 38, pp. 159 - 168, http://dx.doi.org/10.1111/dar.12908
    Journal articles | 2019
    Dr Briony Kate Larance
    Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations', Addiction, vol. 114, pp. 404 - 405, http://dx.doi.org/10.1111/add.14556
    Journal articles | 2018
    Dr Briony Kate Larance
    Cooper S; Campbell G; Larance B; Murnion B; Nielsen S, 2018, 'Perceived stigma and social support in treatment for pharmaceutical opioid dependence', Drug and Alcohol Review, vol. 37, pp. 262 - 272, http://dx.doi.org/10.1111/dar.12601
    Journal articles | 2018
    Dr Briony Kate Larance
    Larance B; Gisev N; Cama E; Nelson EC; Darke S; Larney S; Degenhardt L, 2018, 'Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence', Drug and Alcohol Dependence, vol. 191, pp. 145 - 151, http://dx.doi.org/10.1016/j.drugalcdep.2018.03.056
    Journal articles | 2018
    Dr Briony Kate Larance
    Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B, 2018, 'Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users', Drug and Alcohol Review, vol. 37, pp. 664 - 670, http://dx.doi.org/10.1111/dar.12688
    Journal articles | 2018
    Dr Briony Kate Larance
    Larance B; Dobbins T; Peacock A; Ali R; Bruno R; Lintzeris N; Farrell M; Degenhardt L, 2018, 'The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study', The Lancet Psychiatry, vol. 5, pp. 155 - 166, http://dx.doi.org/10.1016/S2215-0366(18)30003-8
    Journal articles | 2018
    Dr Briony Kate Larance
    Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2018, 'Knowledge of opioid overdose and attitudes to supply of take-home naloxone among people with chronic noncancer pain prescribed opioids', Pain Medicine (United States), vol. 19, pp. 533 - 540, http://dx.doi.org/10.1093/pm/pnx021
    Journal articles | 2018
    Dr Briony Kate Larance
    Nielsen S; Lintzeris N; Murnion B; Degenhardt L; Bruno R; Haber P; Johnson J; Hardy M; Ling S; Saddler C; Dunlop A; Demirkol A; Silsbury C; Phung N; Houseman J; Larance B, 2018, 'Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence', Drug and Alcohol Review, vol. 37, pp. 887 - 896, http://dx.doi.org/10.1111/dar.12859
    Journal articles | 2018
    Dr Briony Kate Larance
    Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L, 2018, 'A nationwide study of the extent and factors associated with fentanyl use in Australia', Research in Social and Administrative Pharmacy, vol. 14, pp. 303 - 308, http://dx.doi.org/10.1016/j.sapharm.2017.04.002
    Journal articles | 2018
    Dr Briony Kate Larance
    Schaffer A; Buckley NA; Degenhardt L; Larance B; Cairns R; Dobbins T; Pearson SA, 2018, 'Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia', Canadian Medical Association Journal, vol. 190, pp. E355 - E362, http://dx.doi.org/10.1503/cmaj.170666
    Journal articles | 2018
    Dr Briony Kate Larance
    Peacock A; Larance B; Farrell M; Cairns R; Buckley N; Degenhardt L, 2018, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A postmarketing study protocol', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-020006
    Journal articles | 2018
    Dr Briony Kate Larance
    Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L, 2018, 'Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study', The Lancet Public Health, vol. 3, pp. e341 - e350, http://dx.doi.org/10.1016/S2468-2667(18)30110-5
    Journal articles | 2018
    Dr Briony Kate Larance
    Pikovsky M; Peacock A; Larney S; Larance B; Conroy E; Nelson E; Degenhardt L, 2018, 'Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study', Drug and Alcohol Dependence, vol. 188, pp. 304 - 310, http://dx.doi.org/10.1016/j.drugalcdep.2018.04.016
    Journal articles | 2018
    Dr Briony Kate Larance
    Blanch B; Degenhardt L; Buckley NA; Gisev N; Dobbins T; Karanges EA; Larance B; Larney S; Pearson SA, 2018, 'Prescription opioid access patterns and factors associated with increasing number of prescribers, pharmacies, and dispensings: An observational study using pharmaceutical claims', Pain Medicine (United States), vol. 19, pp. 1170 - 1183, http://dx.doi.org/10.1093/pm/pnx035
    Journal articles | 2018
    Dr Briony Kate Larance
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L, 2018, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Pharmacoepidemiology and Drug Safety, vol. 27, pp. 550 - 555, http://dx.doi.org/10.1002/pds.4329
    Journal articles | 2017
    Dr Briony Kate Larance
    Nielsen S; Larance B; Lintzeris N, 2017, 'Opioid agonist treatment for patients with dependence on prescription opioids', JAMA - Journal of the American Medical Association, vol. 317, pp. 967 - 968, http://dx.doi.org/10.1001/jama.2017.0001
    Journal articles | 2017
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Peacock A; Gisev N; Mattick R; Colledge S; Campbell G, 2017, 'Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses', Drug and Alcohol Review, vol. 37, pp. S203 - S205, http://dx.doi.org/10.1111/dar.12617
    Journal articles | 2017
    Dr Briony Kate Larance
    Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L, 2017, 'Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment', Pharmacoepidemiology and Drug Safety, vol. 26, pp. 587 - 591, http://dx.doi.org/10.1002/pds.4168
    Journal articles | 2017
    Dr Briony Kate Larance
    Holliday S; Hayes C; Dunlop A; Morgan S; Tapley A; Henderson K; Larance B; Magin P, 2017, 'Protecting pain patients. The evaluation of a chronic pain educational intervention', Pain Medicine (United States), vol. 18, pp. 2306 - 2315, http://dx.doi.org/10.1093/pm/pnx018
    Journal articles | 2017
    Dr Briony Kate Larance
    Jacka B; Peacock A; Degenhardt L; Bruno R; Clare P; Kemp R; Dev A; Larance B, 2017, 'Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015', International Journal of Drug Policy, vol. 46, pp. 74 - 78, http://dx.doi.org/10.1016/j.drugpo.2017.05.048
    Journal articles | 2017
    Dr Briony Kate Larance
    Peacock A; Bruno R; Larance B; Lintzeris N; Ali R; Oen D; Sotade O; White N; Degenhardt L, 2017, 'Same-day use of opioids and depressants: A retrospective diary study', Drug and Alcohol Dependence, vol. 171, pp. e161 - e161, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.444
    Journal articles | 2017
    Dr Briony Kate Larance
    Nielsen S; Larance B; Degenhardt L; Gowing L; Lintzeris N, 2017, 'A systematic review of opioid agonist treatments for pharmaceutical opioid dependence', Drug and Alcohol Dependence, vol. 171, pp. e152 - e153, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.421
    Journal articles | 2017
    Dr Briony Kate Larance
    Campbell G; Bruno R; Cohen M; Hall W; Nielsen S; Lintzeris N; Larance B; Mattick RP; Farrell M; Degenhardt L, 2017, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic non-cancer pain: Different measures, same patients?', Drug and Alcohol Dependence, vol. 171, pp. e33 - e33, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.103
    Journal articles | 2016
    Dr Briony Kate Larance
    Deacon RM; Nielsen S; Leung S; Rivas G; Cubitt T; Monds LA; Ezard N; Larance B; Lintzeris N, 2016, 'Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling', International Journal of Drug Policy, vol. 36, pp. 104 - 111, http://dx.doi.org/10.1016/j.drugpo.2016.06.006
    Journal articles | 2016
    Dr Briony Kate Larance
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N, 2016, 'Opioid agonist treatment for pharmaceutical opioid dependent people', Cochrane Database of Systematic Reviews, vol. 2016, http://dx.doi.org/10.1002/14651858.CD011117.pub2
    Journal articles | 2016
    Dr Briony Kate Larance
    Lintzeris N; Moodley R; Campbell G; Larance B; Bruno R; Nielsen S; Degenhardt L, 2016, 'Sleep quality among people living with chronic noncancer pain: Findings from the pain and opioids in treatment (POINT) cohort', Clinical Journal of Pain, vol. 32, pp. 380 - 387, http://dx.doi.org/10.1097/AJP.0000000000000282
    Journal articles | 2016
    Dr Briony Kate Larance
    Peacock A; Nielsen S; Bruno R; Campbell G; Larance B; Degenhardt L, 2016, 'Geographic variation in health service use and perceived access barriers for Australian adults with chronic non-cancer pain receiving opioid therapy', Pain Medicine (United States), vol. 17, pp. 2003 - 2016, http://dx.doi.org/10.1093/pm/pnw109
    Journal articles | 2016
    Dr Briony Kate Larance
    Larance B; Campbell G; Peacock A; Nielsen S; Bruno R; Hall W; Lintzeris N; Cohen M; Degenhardt L, 2016, 'Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy', Drug and Alcohol Dependence, vol. 162, pp. 79 - 87, http://dx.doi.org/10.1016/j.drugalcdep.2016.02.048
    Journal articles | 2016
    Dr Briony Kate Larance
    Peacock A; Bruno R; Larance B; Lintzeris N; Nielsen S; Ali R; Dobbins T; Degenhardt L, 2016, 'Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study', Drug and Alcohol Dependence, vol. 166, pp. 125 - 133, http://dx.doi.org/10.1016/j.drugalcdep.2016.07.003
    Journal articles | 2016
    Dr Briony Kate Larance
    White N; Ali R; Larance B; Zador D; Mattick RP; Degenhardt L, 2016, 'The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film', Drug and Alcohol Review, vol. 35, pp. 76 - 82, http://dx.doi.org/10.1111/dar.12317
    Journal articles | 2016
    Dr Briony Kate Larance
    Larance B; Mattick R; Ali R; Lintzeris N; Jenkinson R; White N; Kihas I; Cassidy R; Degenhardt L, 2016, 'Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia', Drug and Alcohol Review, vol. 35, pp. 83 - 91, http://dx.doi.org/10.1111/dar.12344
    Journal articles | 2016
    Dr Briony Kate Larance
    Peacock AK; Degenhardt L; Campbell G; Larance B; Nielsen S; Hall W; Mattick RP; Bruno R, 2016, 'A typology of predictive risk factors for non-adherent medication-related behaviors among chronic non-cancer pain patients prescribed opioids: a cohort study', Pain Physician, vol. 19, pp. e421 - e434, http://www.painphysicianjournal.com/current/past?journal=95
    Journal articles | 2016
    Dr Briony Kate Larance
    Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: Do different measures identify the same patients?', Pain, vol. 157, pp. 1489 - 1498, http://dx.doi.org/10.1097/j.pain.0000000000000548
    Journal articles | 2016
    Dr Briony Kate Larance
    Larance B; Bruno R; Lintzeris N; Degenhardt L; Black E; Brown A; Nielsen S; Dunlop A; Holland R; Cohen M; Mattick RP, 2016, 'Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale', Drug and Alcohol Dependence, vol. 159, pp. 42 - 52, http://dx.doi.org/10.1016/j.drugalcdep.2015.11.026
    Journal articles | 2016
    Dr Briony Kate Larance
    Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L, 2016, 'An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 469 - 494, http://dx.doi.org/10.1007/s00228-015-1995-8
    Journal articles | 2016
    Dr Briony Kate Larance
    Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R, 2016, 'The extent and correlates of community-based pharmaceutical opioid utilisation in Australia', Pharmacoepidemiology and Drug Safety, vol. 25, pp. 521 - 538, http://dx.doi.org/10.1002/pds.3931
    Journal articles | 2016
    Dr Briony Kate Larance
    Larney S; Cama E; Nelson E; Larance B; Degenhardt L, 2016, 'A cross-sectional study of correlates of imprisonment in opioid-dependent men and women in New South Wales, Australia', Drug and Alcohol Review, vol. 35, pp. 686 - 692, http://dx.doi.org/10.1111/dar.12357
    Journal articles | 2016
    Dr Briony Kate Larance
    Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, vol. 82, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026
    Journal articles | 2016
    Dr Briony Kate Larance
    Larance B; Copeland J; Burns L; Holden J; Farrell M; Degenhardt L, 2016, 'PHYSICAL HEALTH AND OPPORTUNITIES FOR INTERVENTION AMONG MEN WHO USE PERFORMANCE AND IMAGE ENHANCING DRUGS', DRUG AND ALCOHOL REVIEW, vol. 35, pp. 47 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2015
    Dr Briony Kate Larance
    White N; Flaherty I; Higgs P; Larance B; Nielsen S; Degenhardt L; Ali R; Lintzeris N, 2015, 'Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study', Drug and Alcohol Review, vol. 34, pp. 623 - 629, http://dx.doi.org/10.1111/dar.12308
    Journal articles | 2015
    Dr Briony Kate Larance
    Nielsen S; Lintzeris N; Bruno R; Campbell G; Larance B; Hall W; Hoban B; Cohen ML; Degenhardt L, 2015, 'Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization', Pain Medicine (United States), vol. 16, pp. 356 - 366, http://dx.doi.org/10.1111/pme.12594
    Journal articles | 2015
    Dr Briony Kate Larance
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L, 2015, 'Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids', Drug and Alcohol Review, vol. 34, pp. 611 - 622, http://dx.doi.org/10.1111/dar.12279
    Journal articles | 2015
    Dr Briony Kate Larance
    Larance B; Dietze P; Ali R; Lintzeris N; White N; Jenkinson R; Degenhardt L, 2015, 'The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations', Drug and Alcohol Review, vol. 34, pp. 603 - 610, http://dx.doi.org/10.1111/dar.12277
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Bruno R; Lintzeris N; Hall W; Nielsen S; Larance B; Cohen M; Campbell G, 2015, 'Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): A cohort study', The Lancet Psychiatry, vol. 2, pp. 314 - 322, http://dx.doi.org/10.1016/S2215-0366(15)00005-X
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B, 2015, 'The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study', Drug and Alcohol Dependence, vol. 151, pp. 56 - 67, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.038
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M, 2015, 'Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: The National Opioid Medications Abuse Deterrence (NOMAD) study protocol', Addiction, vol. 110, pp. 226 - 237, http://dx.doi.org/10.1111/add.12746
    Journal articles | 2015
    Dr Briony Kate Larance
    Larance B; Lintzeris N; Bruno R; Peacock A; Cama E; Ali R; Kihas I; Hordern A; White N; Degenhardt L, 2015, 'The characteristics of a cohort who tamper with prescribed and diverted opioid medications', Journal of Substance Abuse Treatment, vol. 58, pp. 51 - 61, http://dx.doi.org/10.1016/j.jsat.2015.06.001
    Journal articles | 2015
    Dr Briony Kate Larance
    Campbell G; Nielsen S; Bruno R; Lintzeris N; Cohen M; Hall W; Larance B; Mattick RP; Degenhardt L, 2015, 'The Pain and Opioids in Treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain', Pain, vol. 156, pp. 231 - 242, http://dx.doi.org/10.1097/01.j.pain.0000460303.63948.8e
    Journal articles | 2015
    Dr Briony Kate Larance
    Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L, 2015, 'Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort', Pain Medicine (United States), vol. 16, pp. 1745 - 1758, http://dx.doi.org/10.1111/pme.12773
    Journal articles | 2015
    Dr Briony Kate Larance
    Smith K; Mattick RP; Bruno R; Nielsen S; Cohen M; Campbell G; Larance B; Farrell M; Degenhardt L, 2015, 'Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain', Journal of Affective Disorders, vol. 184, pp. 72 - 80, http://dx.doi.org/10.1016/j.jad.2015.05.049
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S, 2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, vol. 5, http://dx.doi.org/10.1136/bmjopen-2014-007030
    Journal articles | 2015
    Dr Briony Kate Larance
    Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, vol. 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716
    Journal articles | 2015
    Dr Briony Kate Larance
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L, 2015, 'A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia', Addiction, vol. 110, pp. 646 - 655, http://dx.doi.org/10.1111/add.12834
    Journal articles | 2015
    Dr Briony Kate Larance
    Peacock A; Degenhardt L; Larance B; Cama E; Lintzeris N; Ali R; Bruno R, 2015, 'A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone', Pharmacoepidemiology and Drug Safety, vol. 24, pp. 1321 - 1333, http://dx.doi.org/10.1002/pds.3883
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Gisev N; Cama E; Larance B; Bruno R, 2015, 'Estimating the Extent and Predictors of Pharmaceutical Opioid Use in Australia in 2013', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 24, pp. 25 - 26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Larance B; Peacock A; Farrell M, 2015, 'Reducing extramedical use and harms of pharmaceutical opioids: The potential role of abuse-deterrent formulations', The Lancet Psychiatry, vol. 2, pp. 957 - 959, http://dx.doi.org/10.1016/S2215-0366(15)00331-4
    Journal articles | 2015
    Dr Briony Kate Larance
    Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber PS; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2015, 'LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT', DRUG AND ALCOHOL REVIEW, vol. 34, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2015
    Dr Briony Kate Larance
    Peacock A; Degenhardt L; Lintzeris N; Larance B; Campbell G; Nielsen S; Cohen M; Bruno R, 2015, 'Opioid therapy for chronic non-cancer pain: Does typology of risk predict aberrant behaviour?', Drug and Alcohol Dependence, vol. 156, pp. e173 - e174, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.471
    Journal articles | 2015
    Dr Briony Kate Larance
    Degenhardt L; Bruno R; Lintzeris N; Hall W; Nielsen S; Larance B; Cohen M; Campbell G, 2015, 'Xamining DSM and ICD definitions of pharmaceutical opioid dependence in people taking opioids for chronic pain: Findings from the pain and opioids in treatment study', Drug and Alcohol Dependence, vol. 156, pp. e55 - e55, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.1068
    Journal articles | 2015
    Dr Briony Kate Larance
    Nielsen S; Bruno R; Campbell G; Cohen M; Farrell M; Hall W; Hoban B; Larance B; Lintzeris N; Mattick R; Degenhardt L, 2015, 'Benzodiazepine use among a sample of chronic pain patients prescribed opioids', Drug and Alcohol Dependence, vol. 146, pp. e52 - e52, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.512
    Journal articles | 2015
    Dr Briony Kate Larance
    Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L, 2015, 'Pharmaceutical opioid use and dependence among people living with chronic pain: Associations observed within the pain and opioids in treatment cohort', Drug and Alcohol Dependence, vol. 156, pp. e35 - e35, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.1013
    Journal articles | 2015
    Dr Briony Kate Larance
    Larance B; Peacock A; Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Mattick RP; Degenhardt L, 2015, 'Sex differences in alcohol use disorders and risky drinking among chronic non-cancer pain patients receiving opioid therapy', Drug and Alcohol Dependence, vol. 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.336
    Journal articles | 2014
    Dr Briony Kate Larance
    Peacock A; Degenhardt L; Hordern A; Larance B; Cama E; White N; Kihas I; Bruno R, 2014, 'Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation', International Journal of Drug Policy, vol. 26, pp. 1265 - 1272, http://dx.doi.org/10.1016/j.drugpo.2015.05.023
    Journal articles | 2014
    Dr Briony Kate Larance
    Larance B; Lintzeris N; Ali R; Dietze P; Mattick R; Jenkinson R; White N; Degenhardt L, 2014, 'The diversion and injection of a buprenorphine-naloxone soluble film formulation', Drug and Alcohol Dependence, vol. 136, pp. 21 - 27, http://dx.doi.org/10.1016/j.drugalcdep.2013.12.005
    Journal articles | 2014
    Dr Briony Kate Larance
    Larance B; Carragher N; Mattick RP; Lintzeris N; Ali R; Degenhardt L, 2014, 'A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses?', Drug and Alcohol Dependence, vol. 142, pp. 46 - 55, http://dx.doi.org/10.1016/j.drugalcdep.2014.05.018
    Journal articles | 2014
    Dr Briony Kate Larance
    Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L, 2014, 'Cohort protocol paper: The pain and opioids in treatment (POINT) study', BMC Pharmacology and Toxicology, vol. 15, http://dx.doi.org/10.1186/2050-6511-15-17
    Journal articles | 2014
    Dr Briony Kate Larance
    Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L, 2014, 'A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women', Drug and Alcohol Review, vol. 33, pp. 499 - 505, http://dx.doi.org/10.1111/dar.12151
    Journal articles | 2014
    Dr Briony Kate Larance
    Nielsen S; Degenhardt L; Larance B; Gowing L; Kehler C; Lintzeris N, 2014, 'Opioid agonist treatment for pharmaceutical opioid dependent people: protocol', Cochrane Database of Systematic Reviews, vol. 5, pp. 1 - 12, http://dx.doi.org/10.1002/14651858.CD011117
    Journal articles | 2014
    Dr Briony Kate Larance
    Nielsen S; Larance B; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt L, 2014, 'Is pain associated with illicit opioid use or aberrant opioid-related behaviors in opioid substitution treatment patients', Drug and Alcohol Dependence, vol. 140, pp. e162 - e162, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.456
    Journal articles | 2014
    Dr Briony Kate Larance
    Gisev N; Degenhardt L; Larney S; Dobbins T; Larance B; Gibson A; Kimber J; Butler T; Mattick R; Burns L, 2014, 'Treatment Utilisation and Retention with Opioid Substitution Therapy between 2001 and 2010: A Comparison of Buprenorphine and Methadone Users', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 23, pp. 346 - 347, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600644&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Mattick R; Ali R; Lintzeris N, 2014, 'Australian post-marketing surveillance studies, 2012', Drug and Alcohol Dependence, vol. 140, pp. e115 - e116, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.331
    Journal articles | 2013
    Dr Briony Kate Larance
    Lintzeris N; Leung S; Dunlop A; Larance BK; White N; Rivas GR; Holland RM; Degenhardt LJ; Muhleisen P; Hurley M; Ali R, 2013, 'A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence', Drug and Alcohol Dependence, vol. 131, pp. 119 - 126, http://dx.doi.org/10.1016/j.drugalcdep.2012.12.009
    Journal articles | 2013
    Dr Briony Kate Larance
    Nielsen S; Larance BK; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt LJ, 2013, 'Correlates of pain in an in-treatment sample of opioid-dependent people', Drug and Alcohol Review, vol. 32, pp. 489 - 494, http://dx.doi.org/10.1111/dar.12041/full
    Journal articles | 2013
    Dr Briony Kate Larance
    Belcher J; Nielsen S; Campbell G; Bruno R; Hoban B; Larance B; Lintzeris N; Degenhardt L, 2013, 'Diversion of prescribed opioids by people living with chronic pain: Results from an Australian community sample', Drug Alcohol Rev, vol. 33, pp. 27 - 32, http://dx.doi.org/10.1111/dar.12084
    Journal articles | 2013
    Dr Briony Kate Larance
    Degenhardt LJ; Gilmour S; Shand FL; Bruno R; Campbell G; Mattick RP; Larance BK; Hall W, 2013, 'Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia', Drug and Alcohol Review, vol. Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1111/dar.12066/pdf
    Journal articles | 2013
    Dr Briony Kate Larance
    Shakeshaft A; Larance B; Degenhardt L; Shand F; Mattick RP; Holiday S; Petrie D; Gorman D, 2013, 'COMMUNITY-LEVEL INTERVENTIONS TO IMPROVE THE TREATMENT OF CHRONIC PAIN AND PRESCRIPTION OF PHARMACEUTICAL OPIOIDS IN GENERAL PRACTICE', DRUG AND ALCOHOL REVIEW, vol. 32, pp. 62 - 62, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Briony Kate Larance
    Larance B; Lintzeris N; Ali R; Mattick RP; White N; Jenkinson R; Dietze P; Degenhardt L, 2013, 'THE DIVERSION AND INJECTION OF BUPRENORPHINE-NALOXONE SUBLINGUAL FILM: 2012 FINDINGS FROM THE AUSTRALIAN POST-MARKETING SURVEILLANCE STUDIES', DRUG AND ALCOHOL REVIEW, vol. 32, pp. 46 - 46, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Dr Briony Kate Larance
    Roxburgh AD; Bruno R; Larance BK; Burns L, 2011, 'Prescription of opioid analgesics and related harms in Australia', Medical Journal of Australia, vol. 195, pp. 280 - 284, http://dx.doi.org/10.5694/mja10.11450
    Journal articles | 2011
    Dr Briony Kate Larance
    Horyniak D; Dietze P; Larance BK; Winstock A; Degenhardt LJ, 2011, 'The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia', International Journal of Drug Policy, vol. 22, pp. 167 - 171, http://dx.doi.org/10.1016/j.drugpo.2010.10.004
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Lintzeris N; Winstock A; Mattick RP, 2011, 'Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours', Drug and Alcohol Review, vol. 30, pp. 236 - 245, http://dx.doi.org/10.1111/j.1465-3362.2010.00283.x
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance B; Ambekar A; Azim T; Murthy P; Panda S; Degenhardt L; Mathers B, 2011, 'The availability, diversion and injection of pharmaceutical opioids in South Asia', Drug and Alcohol Review, vol. 30, pp. 246 - 254, http://dx.doi.org/10.1111/j.1465-3362.2011.00304.x
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients', Drug and Alcohol Review, vol. 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Lintzeris N; Bell JR; Winstock A; Dietze P; Mattick RP; Ali RL; Horyniak D, 2011, 'Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised administration', Drug and Alcohol Dependence, vol. 118, pp. 265 - 273, http://dx.doi.org/10.1016/j.drugalcdep.2011.04.002
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; O Brien SM; Lintzeris N; Winstock A; Mattick RP; Bell JR; Ali RL, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opiod substitution treatment patients', Drug and Alcohol Review, vol. 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x/full
    Journal articles | 2011
    Dr Briony Kate Larance
    Larance BK; Ambekar A; Azim T; Murthy P; Panda S; Degenhardt LJ; Mathers BM, 2011, 'The availability, diversion and injection of pharmaceutical opioids in South Asia', Drug and Alcohol Review, vol. 30, pp. 246 - 254, http://dx.doi.org/10.1111/j.1465-3362.2011.00304.x/pdf
    Journal articles | 2010
    Dr Briony Kate Larance
    Phillips B; Larance B; Burns L, 2010, 'THE PREVALENCE AND CORRELATES OF PAIN AMONG A SAMPLE OF PEOPLE WHO INJECT DRUGS REGULARLY', DRUG AND ALCOHOL REVIEW, vol. 29, pp. 58 - 58, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Dr Briony Kate Larance
    Degenhardt LJ; Larance BK; Bell JR; Winstock A; Ali RL; Scheuer N; Mattick RP, 2009, 'Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist¿antagonist formulation', Medical Journal of Australia, vol. 191, pp. 161 - 165
    Journal articles | 2009
    Dr Briony Kate Larance
    Phillips B; Larance B; Burns L, 2009, 'PHARMACEUTICAL OPIOID USE AMONG A GROUP OF PEOPLE WHO INJECT DRUGS IN AUSTRALIA'S LARGEST DRUG MARKET: EXTRA-MEDICAL USE, CHRONIC PAIN AND RISK MANAGEMENT', DRUG AND ALCOHOL REVIEW, vol. 28, pp. A51 - A52, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2008
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Copeland J; Dillon PG, 2008, 'Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs', Drug and Alcohol Review, vol. 27, pp. 679 - 686, http://dx.doi.org/10.1080/09595230802392568
    Journal articles | 2008
    Dr Briony Kate Larance
    Roxburgh AD; Degenhardt LJ; Copeland J; Larance BK, 2008, 'Drug dependence and associated risks among female street-based sex workers in the greater Sydney area, Australia', Substance Use and Misuse, vol. 43, pp. 1202 - 1217, http://dx.doi.org/10.1080/10826080801914410
    Journal articles | 2008
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Copeland J; Dillon P, 2008, 'Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs', Drug and Alcohol Review, vol. 27, pp. 679 - 686, http://dx.doi.org/10.1080/09595230802392568
    Journal articles |
    Dr Briony Kate Larance
    Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 'Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in Mutual Support Groups Coordinated by SMART Recovery Australia: Protocol for a Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15113
  • Reports | 2009
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Mattick RP; O Brien SM; Lintzeris N; Bell JR; Winstock A; Ali RL, 2009, The diversion and injection of the pharmaceutical opioids used in opiod substitution treatment (OST): Findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone 2006-2008, National Drug and Alcohol Research Centre, Sydney, NSW, NDARC Technical Report, 302, http://ndarc.med.unsw.edu.au/resource/diversion-and-injection-pharmaceutical-opioids-used-opioid-substitution-treatment-findings
    Reports | 2008
    Dr Briony Kate Larance
    Dennington V; Finney Lamb CE; Dillon PG; Larance BK; Vial R; Copeland J; Newcombe D; Ali RL, 2008, Qualitative Field Study for Users of Performance and Image Enhancing Drug, Drug and Alcohol Services South Australia, Adelaide, Qualitative Field Study for Users of Performance and Image Enhancing Drug, DASSA Monograph No. 25 Research Series
    Reports | 2007
    Dr Briony Kate Larance
    Degenhardt LJ; Larance BK; Mathers BM; Azim T; Kamarulzaman A; Mattick RP, 2007, Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV., Sydney: National Drug and Alcohol Research Centre, University of NSW., Sydney, Reference Group to the United Nations on HIV and injecting drug use Thematic Paper Series No. 2/2007., 2/2007, http://ndarc.med.unsw.edu.au/resource/benefits-and-risks-pharmaceutical-opioids-essential-treatment-and-diverted-medication
    Reports | 2007
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ, 2007, Performance and image enhancing drugs (PIEDs): Current trends and future monitoring., Sydney: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, IDRS Drug Trends Bulletin, June 2007, June 2007
    Reports | 2006
    Dr Briony Kate Larance
    Gibson AE; Larance BK; Roxburgh AD; Degenhardt LJ; Black E, 2006, The extent of diversion of fentanyl for non-medical purposes in Australia: What do we know?, National Drug and Alcohol Research Centre, University of New South Wales,, Sydney, NDARC Technical Report, 265
    Reports | 2005
    Dr Briony Kate Larance
    Roxburgh AD; Degenhardt LJ; Larance BK; Copeland J, 2005, Mental Health, Drug use and risk among female street-based sex workers in Greater Sydney, National Drug & Alcohol Research Centre, Randwick, NSW, Mental Health, Drug use and risk among female street-based sex workers in Greater Sydney
    Reports | 2005
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Dillon PG; Copeland J, 2005, Rapid assessment of performance and image enhancing drugs (PIEDs) in New South Wales: Feasibility study 2005, National Drug & Alcohol Research Centre, Randwick, NSW, NDARC Technical Reports, 239
    Reports | 2005
    Dr Briony Kate Larance
    Larance BK; Degenhardt LJ; Dillon PG; Copeland J, 2005, Use of performance and image enhancing drugs among men: A review, National Drug & Alcohol Research Centre, Randwick, NSW, Use of performance and image enhancing drugs among men: A review
  • Conference Abstracts | 2020
    Dr Briony Kate Larance
    Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, WILEY, Vol. 206, pp. S57 - S57, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
    Conference Abstracts | 2016
    Dr Briony Kate Larance
    Larance B; Ali R; Farrell M; Peacock A; Bruno R; Lintzeris N; Dobbins T; Degenhardt L, 2016, 'THE IMPACT OF REFORMULATED OXYCONTIN (R) IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 47 - 47, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Briony Kate Larance
    Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2016, 'OVERDOSE KNOWLEDGE AND PERCEPTIONS OF TAKE-HOME NALOXONE FOR PATIENTS WITH CHRONIC NON-CANCER PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 56 - 57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Briony Kate Larance
    Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'DEFINING PROBLEMATIC PHARMACEUTICAL OPIOID USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: DO DIFFERENT MEASURES IDENTIFY THE SAME PATIENTS?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 30 - 30, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Briony Kate Larance
    Moore T; O'Donnell C; Degenhardt L; Campbell G; Nielsen S; Larance B, 2016, 'PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 55 - 56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Briony Kate Larance
    Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Briony Kate Larance
    Holliday S; Dunlop A; Hayes C; Morgan S; Tapley A; Henderson K; Larance B; Shakeshaft A; Magin P, 2015, 'THE EVALUATION OF A BRIEF EDUCATIONAL PAIN MANAGEMENT INTERVENTION AMONGST AUSTRALIAN GENERAL PRACTICE REGISTRARS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Briony Kate Larance
    Larance B; Campbell G; Nielsen S; Bruno R; Lintzeris N; Cohen M; Degenhardt L, 2015, 'HELP-SEEKING FOR OPIOID MEDICATION-RELATED PROBLEMS AMONG A COHORT OF CHRONIC NON-CANCER PAIN PATIENTS PRESCRIBED STRONG OPIOIDS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 39 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2014
    Dr Briony Kate Larance
    Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT', Vol. 33, pp. 7 - 7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2014
    Dr Briony Kate Larance
    Larance B; Nielsen S; Hordern A; Lintzeris N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Brown A; Johnson J; Degenhardt L, 2014, 'PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY', Vol. 33, pp. 6 - 6, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2014
    Dr Briony Kate Larance
    Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'CHARACTERISTICS OF A NATIONAL SAMPLE OF PEOPLE WITH CHRONIC NON-CANCER PAIN PRESCRIBED PRESCRIPTION OPIOIDS', Vol. 33, pp. 6 - 6, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2014
    Dr Briony Kate Larance
    Leung S; Deacon R; Rivas G; Monds L; Cubitt T; Nielsen S; Larance B; Ezard N; Lintzeris N, 2014, 'CHANGES IN ALPRAZOLAM USE AND RELATED HARM AMONG OPIOID TREATMENT PROGRAM CLIENTS FOLLOWING ITS RESCHEDULING TO A SCHEDULE 8 MEDICATION', Vol. 33, pp. 43 - 43, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2014
    Dr Briony Kate Larance
    Larance B; Peacock A; Campbell G; Freckleton S; Smith K; Mattick R; Bruno R; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'ALCOHOL USE DISORDERS, RISKY ALCOHOL CONSUMPTION AND ADVERSE EVENTS AMONG CHRONIC NON-CANCER PAIN PATIENTS RECEIVING OPIOID THERAPY', Vol. 33, pp. 39 - 40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2014
    Dr Briony Kate Larance
    Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Briony Kate Larance
    Cama E; Larance B; Nelson E; Degenhardt L, 2014, 'STIMULANT AND OPIOID DEPENDENCE AS PREDICTORS OF ADULT PERPETRATION OF VIOLENCE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 20 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Briony Kate Larance
    Larance B; Cama E; Nelson E; Degenhardt L, 2014, 'TRANSITIONS FROM HEROIN USE, TO DEPENDENCE AND TREATMENT SEEKING AMONG AN OPIOID-DEPENDENT SAMPLE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 39 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2012
    Dr Briony Kate Larance
    Nielsen S; Larance B; Black E; Lintzeris N; Degenhardt L; Ali R; Cohen M; Dunlop A; Bruno R; Rivas G; Brown A; Holland R, 2012, 'PAIN PREVALENCE, SEVERITY AND INTERFERENCE IN AN AUSTRALIAN OPIOID AGONIST TREATMENT SAMPLE', Vol. 31, pp. 29 - 29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Mattick R; Carragher N, 2012, 'A LATENT CLASS ANALYSIS OF STABILITY AND ADHERENCE INDICATORS AMONG AUSTRALIAN OPIOID SUBSTITUTION THERAPY CLIENTS: DO STABLE CLIENTS RECEIVE MORE TAKEAWAYS?', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 70 - 70, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700216&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2011
    Dr Briony Kate Larance
    Black E; Larance B; Mattick R; Lintzeris N; Degenhardt L; Bruno R; Nielsen S; Murnion B; Cohen M; Ali R; Dunlop A; Holland R, 2011, 'MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA', Vol. 30, pp. 11 - 11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Dr Briony Kate Larance
    Phillips B; Larance B, 2011, 'EXPLORING THE COMPLEX INTERPLAY BETWEEN THE USE OF PHARMACEUTICAL OPIOIDS AND PAIN MANAGEMENT AMONG PEOPLE WHO INJECT DRUGS REGULARLY IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 73 - 73, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Mattick R; Bell J; Winstock A, 2009, 'CHARACTERISTICS OF THE ILLICIT MARKET FOR THE PHARMACEUTICAL OPIOIDS USED IN OPIOID SUBSTITUTION TREATMENT IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A36 - A37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Dr Briony Kate Larance
    Horyniak D; Larance B; Winstock A; Dietze P; Degenhardt L, 2009, 'THE PREVALENCE AND CORRELATES OF BUPRENORPHINE SMOKING AND SNORTING AMONG OPIOID SUBSTITUTION THERAPY (OST) CLIENTS IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A30 - A30, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Dr Briony Kate Larance
    Larance B; Degenhardt L; Mattick R; Winstock A, 2009, 'NON-ADHERENCE AMONG OPIOID SUBSTITUTION TREATMENT CLIENTS: HOW OFTEN DOES IT OCCUR, AND WHY?', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A36 - A36, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

Media